Kirakosyan O, Reimann M, Andersen AB, Bjarnason A, Bakos Á, Dyrhol-Riise AM, McLaughlin AM, Nita C, Pieridou D, Chesov D, Davidavičienė EV, Günther G, Atshemyan H, Muylle I, Solovic I, Bruchfeld J, Manika K, Kuksa L, Codecasa LR, Stosic M, Skowroński M, Makek MJ, Fréchet Jachym M, Knappik M, Santin Met al.(2025) Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe IJTLD Open, 2(2), 101-106 DOI 10.5588/ijtldopen.24.0498, PubMed 39959402
Viermyr HK, Tonby K, Ponzi E, Trouillet-Assant S, Poissy J, Arribas JR, Dyon-Tafani V, Bouscambert-Duchamp M, Assoumou L, Halvorsen B, Tekin NB, Diallo A, De Gastines L, Munthe LA, Murphy SL, Ueland T, Michelsen AE, Lund-Johansen F, Aukrust P, Mootien J, Dervieux B, Zerbib Y, Richard JC, Prével R, Malvy Det al.(2024) Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial EBioMedicine, 111, 105511 DOI 10.1016/j.ebiom.2024.105511, PubMed 39731852
Markussen DL, Wathne JS, Ritz C, van Werkhoven CH, Serigstad S, Bjørneklett RO, Ulvestad E, Knoop ST, Jenum S, Grewal HMS(2024) Determinants of non-adherence to antibiotic treatment guidelines in hospitalized adults with suspected community-acquired pneumonia: a prospective study Antimicrob Resist Infect Control, 13(1), 140 DOI 10.1186/s13756-024-01494-2, PubMed 39580437
